GlassScriptPhysician profile
Mohamed Koronfel
NPI 1619395928
$8,008.93
in general payments reported to CMS, 2019-2025
26 companies · $674 in 2025
The $674 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $3,022 · 2021: $730 · 2022: $1,455 · 2023: $231 · 2024: $1,287 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971 · Education: $189 · Travel and Lodging: $31.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.55 |
| Education | $189.11 |
| Travel and Lodging | $31.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,923.27 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $2,264.28 | 2019-2024 | Senza |
| Medtronic, INC. | $512.31 | 2024-2025 | Intellis Adaptivestim, Mcgrath Mac |
| Boston Scientific Corporation | $505.93 | 2021-2025 | General - Pain Management |
| Collegium Pharmaceutical, INC. | $421.74 | 2019-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $226.54 | 2021-2024 | Relistor |
| Stimwave Technologies Incorporated | $196.41 | 2020 | |
| Abbvie INC. | $176.66 | 2022-2025 | |
| Curonix LLC | $83.19 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $82.79 | 2025 | Senza |
| Stryker Corporation | $73.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $65.85 | 2022-2023 | Seglentis |
| Allergan, INC. | $51.42 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $49.73 | 2025 | |
| Spr Therapeutics, INC | $49.25 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $48.28 | 2024 | Evoke |
| Biotronik Nro, INC. | $48.26 | 2024 | Prospera |
| Redhill Biopharma INC. | $47.91 | 2021 | |
| Avanos Medical | $40.64 | 2020-2023 | Trivisc Sodium Hyaluronate |
| Vertos Medical, INC. | $27.37 | 2021-2024 | Mild Device Kit |
| Averitas Pharma INC. | $23.74 | 2024 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $20.35 | 2022 | |
| Biogen, INC. | $20.26 | 2021 | |
| Lilly USA, LLC | $17.30 | 2022 | |
| Pfizer INC. | $16.40 | 2023 | |
| Medtronic USA, INC. | $15.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Koronfel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.